TERANODE XDA Extended with LIMS Functionality that Transforms Experiment Designs into Automation without Programming, Improves Lab Flexibility and Efficiency
SEATTLE, Wash. -- June 13, 2005 -- Teranode Corporation, the leading innovator of experiment design automation (XDA) software for the Life Sciences industry, today announced the release of TERANODE XDA 2.7, its next-generation model-driven informatics platform and the industry's first model-driven LIMS to transform experiment designs into automation without programming. The new LIMS extensions provide a more cost-effective solution for lab automation compared to traditional methodologies, such as standard databases or spreadsheets. (See also today's press release entitled, "Teranode Improves Lab Flexibility and Efficiency with Launch of New Screening Automation Solution.")
"Model-driven informatics is a significant leap forward, technologically speaking, in the way life science R&D professionals handle data and experiments," said Michael Elliot, principal analyst for Atrium Research. "With model-driven informatics, the effort and time to automate lab procedures can be significantly reduced with the added advantage of streamlining collaboration and enabling a semantically rich web of data."
TERANODE XDA automates data management, flow, and analytics in the lab. The TERANODE XDA platform is comprised of:
TERANODE XDA 2.7: Model-driven LIMS Extensions
TERANODE XDA 2.7 provides a new LIMS application that automates lab protocols without programming, providing the most flexible and cost-effective LIMS solution for life science labs. TERANODE XDA 2.7 includes:
"By incorporating LIMS into our award-winning technology, we've created the only informatics software the supports the entire lifecycle of experimentation," said Joseph Duncan, CEO of Teranode. "TERANODE XDA's model-driven platform eliminates programming costs associated with lab automation allowing labs to put their investment in science rather than database development."
Pricing and Availability
Available immediately, pricing for TERANODE XDA begins at $1,000 per user and $25,000 per server. For additional pricing information, please email sales@teranode.com.
About Teranode Corporation
Teranode Corporation, headquartered in Seattle, WA, is the leading innovator of experiment design automation (XDA) software to improve speed and quality of experimentation for the benefit of accelerated R&D. The company, founded in 2002 to revolutionize the role that computing plays in Life Sciences, began with technologies invented by the founders at the University of Washington. TERANODE XDA is being used by leading pharmaceutical, biotechnology, research, and academic organizations including Pfizer, AstraZeneca, and Fred Hutchinson Cancer Research Center.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.